Ahmedabad: Zydus Lifesciences Limited has announced the successful completion of a USFDA surveillance inspection at its ...

Inmed Pharmaceuticals Inc. ( ($INM) ) has released its Q2 earnings. Here is a breakdown of the information Inmed ...

As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

Currrax Pharmaceuticals over-performed its 2024 revenue goal and has exceeded 50% year-over-year revenue growth for its ...

Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...

Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...

Venkatasubramanian earned his BS in chemical engineering from the University of Madras, an MS in physics from Vanderbilt ...

Health scientists and drug industry executives around the world are on alert after the confirmation of Robert F. Kennedy Jr., who spreads antivaccine misinformation and has often derided the ...

Robert F. Kennedy Jr, a vaccine critic who has pledged to tackle chronic disease, was named U.S. Health Secretary on Thursday ...

A New Hampshire economic official is warning that tariffs imposed by President Donald Trump are causing uncertainty in the marketplace.

Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large manufacturing ...